A causal mechanism by which obesity promotes the progression of breast cancer via the NLRC4 inflammasome activation has been recently described (187) but no results showing the impact of NLRP3 in obesity-associated CRC have been reported. The gene discussed is NLRP3; the disease is obesity due to melanocortin 4 receptor deficiency.